The serum selenium concentration of patients with acute myocardial infarction. 1986

O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz

Serum selenium concentration was determined in 49 patients with acute myocardial infarction within 4 hours after the beginning of the symptoms. The mean serum selenium concentration of the patients was significantly lower than that of healthy controls (55 +/- 15 micrograms/l vs. 78 +/- 11 micrograms/l). Among the 49 patients with acute myocardial infarction 20 (41%) had serum selenium concentration below the 95% percentile of the healthy control group. It is concluded that the low serum selenium concentration was present in these patients before the acute event and was not a consequence of the myocardial infarction. No relationship was found in this study between the serum selenium concentration and the severity of myocardial infarction if the number of coronary vessels occluded is taken as the criterion of severity. Serum selenium concentration was similar in patients with 1 or more coronary vessels occluded. Patients with anterior or posterior myocardial infarction had similar serum selenium concentrations. A positive correlation was observed between serum selenium concentration and total serum creatine kinase (CK) activity and serum myoglobin (MB). The serum selenium concentration correlated negatively with the ratio CK-MB/total CK activity, which can be interpreted as minor injury of mitochondria during infarction in patients with normal serum selenium concentration.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009211 Myoglobin A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012643 Selenium An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE. Selenium-80,Selenium 80

Related Publications

O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
September 1992, Angiology,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
February 1974, Chest,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
August 1983, British medical journal (Clinical research ed.),
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
May 1993, Health bulletin,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
January 2018, PloS one,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
November 1993, Japanese circulation journal,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
January 2015, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
July 2017, BMC cardiovascular disorders,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
January 2012, JAMA,
O Oster, and M Drexler, and J Schenk, and T Meinertz, and W Kasper, and C J Schuster, and W Prellwitz
February 2024, BMC cardiovascular disorders,
Copied contents to your clipboard!